American College of Allergy, Asthma, and Immunology Releases Guidance on Risk of Allergic Reactions to the Pfizer-BioNTech COVID-19 Vaccine

With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine.

Show Rates for Asthma Visits During COVID-19 Increased Thanks to Telemedicine

A new study being presented at this year’s virtual ACAAI Annual Scientific Meeting reveals that “show rates” for children with asthma – how often parents brought their kids to an appointment rather than being a “no show” – increased with the use of telemedicine during four months of the pandemic.